GFM
LEGN icon

GF Fund Management’s Legend Biotech LEGN Stock Holding History

GF Fund Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34K Buy
1,881
+227
+14% +$4.33K ﹤0.01% 446
2025
Q4 		$36K Sell
1,654
-158
-9% -$4.53K ﹤0.01% 438
2025
Q3 		$59.1K Sell
1,812
-280
-13% -$10.3K ﹤0.01% 377
2025
Q2 		$74.2K Hold
2,092
– – ﹤0.01% 388
2025
Q1 		$71K Buy
2,092
+377
+22% +$13.5K ﹤0.01% 389
2024
Q4 		$55.8K Buy
+1,715
New +$71K ﹤0.01% 381

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

GF Fund Management's LEGN Position: Q1 2026 in Review

GF Fund Management increased its Legend Biotech (LEGN) stake by 14% in Q1 2026, buying an estimated $4.33K and bringing the position to 1,881 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #446.

GF Fund Management first reported a position in LEGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $74.2K in Q2 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • GF Fund Management held 1,881 shares of Legend Biotech worth $34K as of Q1 2026.
  • GF Fund Management bought 227 Legend Biotech shares in Q1 2026, an estimated $4.33K.
  • Legend Biotech made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #446 holding.
  • GF Fund Management first reported a position in Legend Biotech in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Legend Biotech position peaked at $74.2K in Q2 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.